Coya Therapeutics Market Risk Adjusted Performance
| COYA Stock | | | 4.84 0.05 1.04% |
Coya Therapeutics market risk adjusted performance lookup summarizes this and related technical indicators for Coya Therapeutics Common. Coverage varies by data normalization and availability; see
Equity Screeners for broader screening context. Use
Trending Equities to better understand diversified portfolio construction. Such insight adds context to allocation decisions within a diversified portfolio. This includes a position in Coya Therapeutics Common within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in unemployment.
Coya Therapeutics Common has current Market Risk Adjusted Performance of
-0.32.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.32 | |
| ER[a] | = | Expected return on investing in Coya Therapeutics |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Coya Therapeutics Market Risk Adjusted Performance Peers Comparison
Coya Market Risk Adjusted Performance Relative To Other Indicators
Coya Therapeutics Common is rated
below average. in market risk adjusted performance category among its top compatitors. It is currently under evaluation. in maximum drawdown category among its top compatitors .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.